A highly efficient continuous synthesis has been developed for telmisartan, the active ingredient in the antihypertensive drug, Micardis. This synthetic route employs a convergent strategy that requires no intermediate purifications or solvent exchanges. The key step in the reaction scheme is a Suzuki cross-coupling reaction between two functionalized benzimidazoles that is catalyzed by a solid-supported Pd catalyst. This flow-based approach utilizes a tubular reactor system coupled with a plug flow packed bed cartridge unit that produces telmisartan in an 81% isolated yield.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Martin, A. D., Siamaki, A. R., Belecki, K., & Gupton, B. F. (2015). A flow-based synthesis of telmisartan. Journal of Flow Chemistry, 5(3), 145–147. https://doi.org/10.1556/JFC-D-15-00002